Clinical Operations 2025: Adapting to Market Shifts and Provider Strategy

Pharma enterprises are facing multiple challenges, including loss of exclusivity and declining R&D productivity, pushing them to rethink their clinical operations strategies. At the same time, technology advancements are transforming the clinical operations landscape, leading providers to innovate rapidly.

Watch this LinkedIn Live session to explore the major challenges pharma companies encountered in 2024 and how these are reshaping clinical operations. We’ll also dive into how evolving technology is driving transformation and what this means for selecting the right providers – from product and CROs to IT/BP service providers. ️

Participants gained valuable insights into how pharma enterprises should evolve their sourcing strategies and how providers can prepare for the growth opportunities and market dynamics of 2025.

During this collaborative LinkedIn Live session, we discussed:

• What challenges do pharma enterprises face, and how do these impact clinical operations?
• What are the evolving technology trends impacting clinical operations?
• How are pharma enterprises evolving their sourcing criteria for this space?
• What is Everest Group’s take on the market sentiment for clinical operations in 2025?